Yes, DNA-based prenatal screening can start around 10 weeks, and tests like CVS or amniocentesis can confirm certain findings later.
Pregnancy brings a lot of decisions, and genetic testing sits near the top of the list for many families. The terms get blurry fast: “DNA test,” “genetic screen,” “NIPT,” “CVS.” This page clears up what each one means, when it can be done, and what kind of answer you’ll get.
You’ll see two tracks throughout: screening tests that estimate chance, and diagnostic tests that can confirm many chromosome findings. Once that split is clear, the rest starts to feel manageable.
What Counts As A Prenatal DNA Test
Most people mean one of three things when they say “DNA test” in pregnancy:
- Cell-free DNA screening (cfDNA): a blood test that reads DNA fragments from the placenta that circulate in the pregnant person’s blood.
- Diagnostic sampling: CVS or amniocentesis, where a clinician collects placental or fetal cells for lab testing.
- Targeted genetic testing: extra testing ordered for a specific family condition, usually using a CVS or amniocentesis sample.
ACOG separates prenatal genetic screening from diagnostic testing and explains when each is used in routine care: Prenatal Genetic Screening Tests and Prenatal Genetic Diagnostic Tests.
DNA Testing During Pregnancy Rules With Real Timing
The “best” test depends on where you are in pregnancy and what you want from the result. Here’s the practical timing picture used in many clinics:
- Week 10 and later: cell-free DNA screening is often available.
- Weeks 10–13: CVS is commonly offered at many centers.
- Weeks 15–20: second-trimester blood screening and the main anatomy ultrasound are often scheduled.
- Week 15 and later: amniocentesis is commonly offered in the mid-trimester.
If you want a clinician-facing summary of how cfDNA should be used, ACOG publishes guidance that also repeats one simple point: cfDNA is still screening, even when it performs well: Current ACOG Guidance.
Screening Tests: What They Can And Can’t Tell You
Screening tests are built to sort people into “lower chance” and “higher chance” groups for certain conditions. They can reduce uncertainty, but they do not confirm a diagnosis.
Cell-free DNA screening
Cell-free DNA screening is a blood draw. It usually targets trisomy 21 (Down syndrome), trisomy 18, and trisomy 13. Some labs also add sex chromosome findings or microdeletion panels. Those add-ons can be harder to interpret, so ask what your clinic orders and why.
If a cfDNA report comes back “no call” or “inconclusive,” it can mean the lab did not have enough fetal fraction or the sample did not meet quality thresholds. Clinics may offer a redraw or a different testing path based on your situation.
Serum screening and ultrasound
First- and second-trimester blood screening looks at hormones and proteins in blood, sometimes paired with ultrasound markers. The anatomy ultrasound can also spot structural findings that raise concern for certain chromosome conditions. Ultrasound can’t read DNA, but it can change how you interpret a screening result.
Diagnostic Tests: CVS And Amniocentesis
Diagnostic testing is the usual next step after a higher-chance screen, or when there’s a strong reason to test from the start. It involves collecting cells for lab testing. These procedures are not routine for all pregnancies, and the decision is personal.
CVS
CVS collects a small sample of placental tissue. The lab can test chromosomes and, when ordered, run targeted genetic testing. MedlinePlus describes CVS as a genetic test performed during pregnancy on chorionic villus cells from the placenta: Chorionic Villus Sampling (CVS).
CVS is often available earlier than amniocentesis. Earlier timing can mean earlier results, which some families prefer.
Amniocentesis
Amniocentesis uses ultrasound guidance to take a small amount of amniotic fluid with a thin needle. Labs can use the sample for chromosome testing and other tests ordered for a specific reason. Many centers start offering it around week 15.
Both CVS and amniocentesis carry some risk. The exact risk depends on the center, clinician experience, and the reason for the procedure. Ask your clinic for their own complication rates and what symptoms should trigger a same-day call.
How Labs Test The Sample
Once a sample reaches the lab, testing can be done in a few ways. The method shapes what the result can show.
- Karyotype: a chromosome picture that can detect larger changes.
- Microarray: a higher-resolution test that can detect smaller copy-number changes.
- Targeted testing: a focused test for a known gene change when there’s a clear reason to look for it.
If your clinician orders a diagnostic procedure, ask which lab method is planned and what that method does not include.
Table: Testing Choices, Timing, And What You Get Back
| Test Or Step | When It’s Often Done | Type Of Answer |
|---|---|---|
| Carrier screening (parents) | Before pregnancy or any trimester | Shows if parents carry certain gene variants |
| Cell-free DNA (cfDNA) screening | Week 10 and later | Chance estimate for selected chromosome conditions |
| First-trimester serum + ultrasound markers | Weeks 9–13 | Chance estimate for selected chromosome conditions |
| Second-trimester serum screening (“quad”) | Weeks 15–20 | Chance estimate; may screen for open neural tube defects |
| Anatomy ultrasound | Weeks 18–22 | Findings that can raise concern or offer reassurance |
| Chorionic villus sampling (CVS) | Often weeks 10–13 | Diagnostic lab result from placental cells |
| Amniocentesis | Often week 15 and later | Diagnostic lab result from amniotic fluid cells |
| Targeted fetal gene testing | After CVS or amnio sample | Checks a specific inherited condition when there’s a clear reason |
Reading Your Results Without Panic
Results are often delivered by phone, portal message, or a clinic visit. Some reports use “positive/negative,” while others use “high chance/low chance.” Either way, ask for these three details:
- What condition was tested? Many tests include only a short list.
- Is this screening or diagnostic? The next step depends on that label.
- What follow-up is suggested? Redraw, ultrasound review, or diagnostic confirmation.
A screening result is a probability statement. A diagnostic result is closer to a yes/no answer for the specific test ordered, yet it still has limits based on scope.
Questions That Save Regret Later
Before you agree to a test, ask questions that match the way the result will land in your life.
- What would I do with a higher-chance result? If you know you’d want confirmation, ask about CVS versus amniocentesis timing right away.
- Do I want sex chromosome findings or microdeletion panels? If yes, ask how often those results lead to extra testing.
- How are results shared? Phone call, portal message, or visit. Pick what feels steady for you.
- What will it cost? Ask about insurance benefits and self-pay price ranges before the blood draw.
It also helps to ask who will explain the report line-by-line. Some clinics arrange a genetics visit for complex results so you’re not guessing from a PDF.
Table: Common Scenarios And Next Questions
| Scenario | What It Usually Means | Question To Ask Next |
|---|---|---|
| Low chance screening result | Chance estimate is below the lab cutoff | “Which conditions were screened, and which were not?” |
| High chance screening result | Chance estimate is above the cutoff | “What diagnostic test can confirm this in my timing window?” |
| No call / inconclusive | Lab could not report a result from the sample | “Is a redraw enough, or should we move to diagnostic testing?” |
| Ultrasound finding plus normal screen | Screen may not include the underlying cause | “Should we add diagnostic testing or a targeted gene test?” |
| Variant of uncertain meaning | Change found, meaning not clear | “Can a genetics visit walk us through what this might mean?” |
| Confirmed diagnostic finding | A chromosome or gene change was identified | “What changes in pregnancy care and newborn planning should we expect?” |
| Normal diagnostic result | No tested change found in the sampled cells | “What does this method miss, and what follow-up imaging is planned?” |
When Screening Is Enough And When Diagnosis Makes Sense
Some people want a low-chance screen and move on. Others want a diagnostic answer so they are not living inside a probability. Your choice can shift based on history and on what you’d do with a result.
Screening often fits when you want a risk estimate with no procedure. Diagnostic testing tends to fit when a screening result is high chance, when ultrasound shows a finding that needs clarification, or when a known inherited condition is in the family.
One practical way to pick is to decide in advance what would trigger a diagnostic test. If your answer is “a high-chance screen would send me straight to confirmation,” ask your clinician about CVS versus amniocentesis timing before you order the screen. That keeps you from scrambling after a phone call.
Also ask whether you should run more than one screen. Many clinicians advise picking one screening approach instead of stacking tests, since mixing screens can create confusing risk math and duplicate anxiety.
If You’re Late To The Testing Window
Many people learn about genetic testing after the first trimester. You still have choices. cfDNA screening is often offered later than week 10, and mid-trimester ultrasound can guide next steps. Diagnostic testing may also be offered later in pregnancy based on timing and the reason for testing.
If you feel rushed, anchor yourself with one concrete number: your gestational age in weeks and days. Then ask your clinic what tests still fit your window and what each one can answer.
Takeaway Points For Today
- DNA-based screening can be done during pregnancy, often starting at week 10.
- Screening estimates chance. CVS and amniocentesis can confirm many findings.
- Ask what is included, what is excluded, and what follow-up is suggested for each possible result.
- Pick the test that matches your goal, not the one with the longest marketing list.
References & Sources
- American College of Obstetricians and Gynecologists (ACOG).“Prenatal Genetic Screening Tests.”Explains screening methods and the difference between screening and diagnosis.
- American College of Obstetricians and Gynecologists (ACOG).“Prenatal Genetic Diagnostic Tests.”Describes CVS and amniocentesis and what diagnostic testing can confirm.
- American College of Obstetricians and Gynecologists (ACOG).“Current ACOG Guidance.”States how cfDNA screening should be used and reinforces that it remains screening.
- MedlinePlus (National Library of Medicine).“Chorionic Villus Sampling (CVS).”Defines CVS and its role as a genetic test performed during pregnancy.
Mo Maruf
I created WellFizz to bridge the gap between vague wellness advice and actionable solutions. My mission is simple: to decode the research and give you practical tools you can actually use.
Beyond the data, I am a passionate traveler. I believe that stepping away from the screen to explore new environments is essential for mental clarity and physical vitality.